BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11734768)

  • 1. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation.
    Davies HD; Raj S; Adair C; Robinson J; McGeer A;
    Pediatr Infect Dis J; 2001 Sep; 20(9):879-84. PubMed ID: 11734768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.
    Nanduri SA; Petit S; Smelser C; Apostol M; Alden NB; Harrison LH; Lynfield R; Vagnone PS; Burzlaff K; Spina NL; Dufort EM; Schaffner W; Thomas AR; Farley MM; Jain JH; Pondo T; McGee L; Beall BW; Schrag SJ
    JAMA Pediatr; 2019 Mar; 173(3):224-233. PubMed ID: 30640366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
    Jordan HT; Farley MM; Craig A; Mohle-Boetani J; Harrison LH; Petit S; Lynfield R; Thomas A; Zansky S; Gershman K; Albanese BA; Schaffner W; Schrag SJ;
    Pediatr Infect Dis J; 2008 Dec; 27(12):1057-64. PubMed ID: 18989238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore.
    Kam KQ; Thoon KC; Tee WSN; Ang MLT; Tan NWH; Yeo KT; Li J; Chong CY
    BMC Infect Dis; 2021 Dec; 21(1):1221. PubMed ID: 34876053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
    Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
    Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study.
    Kalliola S; Vuopio-Varkila J; Takala AK; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):806-10. PubMed ID: 10493342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance of early onset disease due to group B streptococci in newborns.
    Straková L; Motlová J
    Indian J Med Res; 2004 May; 119 Suppl():205-7. PubMed ID: 15232196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.
    Alhhazmi A; Hurteau D; Tyrrell GJ
    J Clin Microbiol; 2016 Jul; 54(7):1774-1781. PubMed ID: 27098960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group B streptococcus neonatal invasive infections, France 2007-2012.
    Joubrel C; Tazi A; Six A; Dmytruk N; Touak G; Bidet P; Raymond J; Trieu Cuot P; Fouet A; Kernéis S; Poyart C
    Clin Microbiol Infect; 2015 Oct; 21(10):910-6. PubMed ID: 26055414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological Characterization of Group B Streptococcus Infections in Alberta, Canada: An Update from 2014 to 2020.
    Ma A; Thompson LA; Corsiatto T; Hurteau D; Tyrrell GJ
    Microbiol Spectr; 2021 Dec; 9(3):e0128321. PubMed ID: 34762517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial Clustering of Late-Onset Group B Streptococcal Infections in the Neonatal Unit: A Genomic Re-evaluation of Causality.
    Jauneikaite E; Kapatai G; Davies F; Gozar I; Coelho J; Bamford KB; Simone B; Begum L; Katiyo S; Patel B; Hoffman P; Lamagni T; Brannigan ET; Holmes AH; Kadhani T; Galletly T; Martin K; Lyall H; Chow Y; Godambe S; Chalker V; Sriskandan S
    Clin Infect Dis; 2018 Aug; 67(6):854-860. PubMed ID: 29509833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
    Dangor Z; Cutland CL; Izu A; Kwatra G; Trenor S; Lala SG; Madhi SA
    PLoS One; 2016; 11(12):e0169101. PubMed ID: 28036363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program.
    Harrison LH; Elliott JA; Dwyer DM; Libonati JP; Ferrieri P; Billmann L; Schuchat A
    J Infect Dis; 1998 Apr; 177(4):998-1002. PubMed ID: 9534974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan.
    Lo CW; Liu HC; Lee CC; Lin CL; Chen CL; Jeng MJ; Chiu CH
    J Microbiol Immunol Infect; 2019 Aug; 52(4):578-584. PubMed ID: 29100794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of invasive group B streptococcal disease in infants from urban area of South China, 2011-2014.
    Guan X; Mu X; Ji W; Yuan C; He P; Zhang L; Huang Y; Li J; Chen J; Zhong H; Pang S; Tan N; Deng Q; Gao K; Huang YP; Chang CY; Liu H
    BMC Infect Dis; 2018 Jan; 18(1):14. PubMed ID: 29310577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.
    Seale AC; Koech AC; Sheppard AE; Barsosio HC; Langat J; Anyango E; Mwakio S; Mwarumba S; Morpeth SC; Anampiu K; Vaughan A; Giess A; Mogeni P; Walusuna L; Mwangudzah H; Mwanzui D; Salim M; Kemp B; Jones C; Mturi N; Tsofa B; Mumbo E; Mulewa D; Bandika V; Soita M; Owiti M; Onzere N; Walker AS; Schrag SJ; Kennedy SH; Fegan G; Crook DW; Berkley JA
    Nat Microbiol; 2016 May; 1(7):16067. PubMed ID: 27572968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B Streptococcal infection in neonates and colonization in pregnant women: An epidemiological retrospective analysis.
    Cho CY; Tang YH; Chen YH; Wang SY; Yang YH; Wang TH; Yeh CC; Wu KG; Jeng MJ
    J Microbiol Immunol Infect; 2019 Apr; 52(2):265-272. PubMed ID: 28882582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for preventing infant invasive GBS disease through maternal vaccination.
    Madhi SA; Dangor Z
    Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.